Delivery Order SPE2DB22D1017-SPE2DB25FG4UM

Award Date 6/11/25
Potential Completion Date 6/12/25
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S medical products to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $3,353.02. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of June 9, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a firm fixed price of $1,731.28. The contract has an ultimate completion date of May 19, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 18, 2024 with a ceiling value of $4,506.10. The contract is a Delivery Order with a Firm Fixed Price type and has a completion date of June 20, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 7, 2025, with a ceiling value of $1,181.76 and a completion date of March 10, 2025. The contract is a Delivery Order under a Firm Fixed Price arrangement. This award is not associated with a set-aside designation....
This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $19,124.16. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of May 15, 2025. The contract is not set aside and is open to competition. Amerisourcebergen Drug...
This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $10,845.70. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the period of performance extends through May 20, 2025. The contract is not set aside and was awarded on an open competition basis....
This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S medical supplies, with a ceiling value of $1,397.90 and an ultimate completion date of July 1, 2024. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract is a Delivery Order under an existing Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S to the Medical Supply Chain, a division of the Defense Logistics Agency (DLA). The $17,441.85 firm fixed-price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 23, 2024. The contract is not set aside and has an ultimate completion date of August 26, 2024. This award is likely part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S to the Defense Logistics Agency (DLA), a defense agency. The $9,349.77 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 13, 2025, with a completion date of February 14, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The federal contract award is for the delivery of 4564960173 - LIDOCAINE 5% PATCH 30S to the U.S. Defense agency, specifically the Medical Supply Chain program. The award was made to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, and has a ceiling value of $4,137.60. The contract is a firm fixed price Delivery Order with a completion date of June 21, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FG4UM
    Delivery Order

This federal contract award is for the delivery of LIDOCAINE 5% PATCH 30S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 11, 2025, with a ceiling value of $3,890.21. The contract is a firm fixed-price delivery order with a completion date of June 12, 2025. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 9/10/25, 9:57 AM